The EORTC Quality of Life Group (QLG) aims to better understand the effects of cancer and its treatments on health-related quality of life (HRQoL) for patients across diverse populations and cultures.
Members of the group develop and refine questionnaires for use in clinical trials, research and clinical practice. They also collaborate with other EORTC disease-oriented groups to implement quality of life measurement in clinical trials.